Morphological variants of plasma cell tumours

Histopathology

Volumn 44, Issue 1, 2004, Pages 2-8

  Banerjee, S S ^a   Verma, S ^a   Shanks, J H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Morphological variation; Myeloma; Plasmacytoma; Review

Indexed keywords

CALCIFICATION; CELL STRUCTURE; CLEAR CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; ERYTHROPHAGOCYTOSIS; HISTOPATHOLOGY; HUMAN; MYELOMA; OSSIFICATION; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW; SIGNET RING CARCINOMA; SPINDLE CELL CARCINOMA; TUMOR DIFFERENTIATION;

HUMANS; PLASMA CELLS; PLASMACYTOMA;

EID: 0842265260     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01763.x     Document Type: Review

References (23)

1. Hayhoe FGJ, Swirsky DM, Bevan PC. Morphological Aspects. In Delamore IW ed. Multiple myeloma and other paraproteinaemias. Edinburgh: Churchill Livingstone. 1986; 75-101.
2. Bartl R, Frisch B, Fateh-Moghadem A, Kettner G, Jaeger K. Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am. J. Clin. Pathol. 1987; 87; 342-355.
3. Gatter K, Brown D. Multiple myeloma. In Gatter K, Brown D eds. An illustrated guide to bone marrow diagnosis. Oxford: Blackwell Science, 1997; 101-109.
4. Nandedkar MA, Abbondanzo SL, Miettinen M. Extramedullary manifestation of multiple myeloma (systemic plasmacytoma) that simulates hemangioma. Arch. Pathol. Lab. Med. 2000; 124; 628-631.
5. Pambuccian SE, Horyd ID, Cawte T, Huvos AG. Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of 3 cases and review of the literature. Am. J. Surg. Pathol. 1997; 21; 179-186.
6. Reinus WR, Kyriakos Gilula LA, Brower AC, Merkel K. Plasma cell tumours with calcified amyloid deposition mistaken for chondrosarcoma. Radiology 1993; 189; 505-509.
7. Karasick D, Schweitzer ME, Miettinen M, O'Hara BJ. Osseous metaplasia associated with amyloid-producing plasmacytoma of bone: a report of two cases. Skeletal Radiol. 1996; 25; 263-267.
8. Gutmann EJ. Granulomatous inflammation related to amyloid deposition in a focus of multiple myeloma. Report of a case with diagnosis by fine needle aspiration biopsy. Acta. Cytol. 1995; 39; 793-797.
9. Maldonado JE, Bayrd ED, Brown AL. The flaming cell in multiple myeloma. Am. J. Clin. Pathol. 1965; 44; 605-612.
10. Zukerberg LR, Ferry JA, Conlon M, Harris NL. Plasma cell myeloma with cleaved, multilobated, and monocytoid nuclei. Am. J. Clin. Pathol. 1990; 93; 657-661.
11. Eyden BP, Banerjee SS. Multiple myeloma showing signet-ring cell change. Histopathology 1990; 17; 170-172.
12. Chen KT, Ma CK, Nelson JW. Clear cell myeloma. Am. J. Surg. Pathol. 1985; 9; 149-154.
13. Susnerwala SS, Shanks JH, Banerjee SS, Scarffe JH, Farrington WT, Slevin NJ. Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases. Br. J. Cancer 1997; 75; 921-927.
14. Bosman C, Fusilli S, Bisceglia M, Musto P, Corsi A. Oncocytic nonsecretory multiple myeloma. A clinicopathologic study of a case and review of the literature. Acta Haematol. 1996; 96; 50-56.
15. Pillai G, Lwin K, Pezzella F, Gatter K. Malignant plasmacytosis mimicking erythrophagocytosis. Histopathology 2002; 41; 468-470.
16. Fitchen JH, Lees S. Phagocytic myeloma cells. Am. J. Clin. Pathol. 1979; 71; 722-723.
17. Scott AE, Knowles DM. Expression of CD56/neural cell adhesion molecule in multiple myeloma correlates with the presence of lytic bone lesions and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphoplasmacytoid differentiation. Am. J. Pathol. 2002; 160; 1293-1299.
18. Wotherspoon AC, Norton AJ, Isaacson PG. Immunoreactive cytokeratins in plasmacytomas. Histopathology 1989; 14; 141-150.
19. Petruch UR, Horny HP, Kaiserling E. Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 1992; 20; 35-40.
20. Govender D, Harilal P, Dada M, Chetty R. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells. J. Clin. Pathol. 1997; 50; 490-493.
21. Menke DM, Horny HP, Griesser H, Atkinson EJ, Kaiserling E, Kyle RA. Immunophenotyping and genotyping of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45R0 (UCHL-1). J. Clin. Pathol. 1998; 51; 432-437.
22. Vasef MA, Medeiros LJ, Yospur LS, Sun NC, McCourty A, Brynes RK. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod. Pathol. 1997; 10; 927-932.
23. San Miguel JF, Gonzalez M, Gascon A et al. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) co-operative group for the study of monoclonal gammopathies. Br. J. Haematol. 1991; 77; 185-190.